上游结合蛋白-1通过诱导NRG2-介导的转移,可塑性和巨细胞极化来促进乳腺瘤发生
Apurva Jaiswal1, Manorma Negi1, Eun Ha Choi1
1Plasma Bioscience Research Center/Department of Electrical and Biological Physics, Kwangwoon University, Seoul 01897, Republic of Korea.
上游结合蛋白1 (UBP1) 通过促进EMT,干性和免疫抑制来推动乳腺癌的进展. 升高的UBP1水平表明预后不佳,并建议它作为治疗目标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 上游结合蛋白1 (UBP1),一种转录因子,涉及到各种生物过程.
- 虽然相关因素与癌症有关,但UBP1在乳腺癌 (BC) 中的作用尚不清楚.
研究的目的:
- 研究UBP1在乳腺癌进展中的新功能.
- 确定UBP1作为BC预后标志物和治疗点的潜力.
主要方法:
- 在线数据库查以将UBP1水平与BC预后相关联.
- 对UBP1对BC细胞上皮质-介质细胞转换 (EMT),干性和信号通路 (PI3K-Akt) 的影响的实验分析.
- 评估UBP1对瘤相关巨细胞 (TAM) 两极化和瘤转移的影响.
主要成果:
- 乳腺癌中UBP1表达升高与预后不佳和不良的临床结果相关.
- UBP1促进BC细胞中的EMT和干细胞,调节PI3K-Akt通路.
- UBP1影响TAM偏向免疫抑制表型,通过NRG2/Akt轴驱动瘤进展和转移.
结论:
- UBP1通过EMT,茎性和免疫调节在侵袭性乳腺癌的进展中发挥着关键作用.
- UBP1表达水平与总体和无复发生存率的降低有关.
- UBP1代表了潜在的预后生物标志物和乳腺癌的治疗点.
更多相关视频
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Regulation of Angiogenesis and Blood Supply
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
